αααααβααΎαNBTX β’ NASDAQ
add
Nanobiotix SA - ADR
4.73$
18 αα»ααΆ, 8:30:00 PM ααααβααα -4 · USD · NASDAQ · ααα
ααααΈαααααΆααα·αααα½ααα»αααααΌα
αα·αααΈαα»α
4.96$
α
αααααααααααα
4.72$ - 4.83$
α
ααααααα½αααααΆαα
α»αααααα
4.14$ - 8.96$
ααΎαβαα»αβααΈααααΆα
227.12Β ααΆα USD
ααα ααα½αααΌαααααα
10.54Β ααΆαα
ααααααΆαααΈααααΆα
α α·ααααααααα»
αααΆαααΆαααααααΆααα
αααΌα
α
αααΌα
α
αααΌααα»ααα
(EUR) | αα·αα»ααΆ 2024info | ααΆαααααΆααααααΌαααΆαβααααΆα |
---|---|---|
α
αααΌα | 4.64Β ααΆα | 182.08% |
α
αααΆαααααα·ααααα·ααΆα | 16.41Β ααΆα | 14.48% |
α
αααΌααα»ααα | -10.94Β ααΆα | 22.16% |
ααααΆααα
αααααα»ααα | -235.46 | 72.41% |
βα
αααΌααα»αααβαααα»ααα½αααΆαα αα»α | β | β |
α
αααΌααα»ααααα»αααΆαααααΆαα αααα ααΆαααααα αα·αααΆαααΆααααααα | -11.62Β ααΆα | 5.65% |
α’ααααΆαααααααααΆαααααα·αααααΆα | -0.66% | β |
αααααΈαααα»ααα
ααααααααα»α
ααΆαααα½ααα»αααααΌαααα»α
(EUR) | αα·αα»ααΆ 2024info | ααΆαααααΆααααααΌαααΆαβααααΆα |
---|---|---|
ααΆα
αααααΆαα αα·αααΆααα·αα·αααααααααααααΈ | 66.34Β ααΆα | 206.69% |
ααααααααα»α | 86.68Β ααΆα | 114.52% |
ααΆαααα½ααα»αααααΌαααα»α | 108.46Β ααΆα | 15.15% |
ααΌαβααααα»α | -21.78Β ααΆα | β |
ααΆαα αα»αβαα·αβααΆααααΆαααα | 47.40Β ααΆα | β |
ααααααααααΉαααααα
| -10.78 | β |
ααα
ααααααΎαααααα | -33.93% | β |
ααα
ααααααΎααΎααα»α | -107.38% | β |
ααα αΌαβααΆα
αβααααΆααβ
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα
(EUR) | αα·αα»ααΆ 2024info | ααΆαααααΆααααααΌαααΆαβααααΆα |
---|---|---|
α
αααΌααα»ααα | -10.94Β ααΆα | 22.16% |
ααΆα
αααααΆααααΈααααα·ααααα·ααΆα | -2.92Β ααΆα | 66.22% |
ααΆα
αααααΆααααΈααΆααα·αα·ααα | -250.00Β ααΆαα | -52.91% |
ααΆα
αααααΆααααΈα α·ααααβαααααΆα | -1.33Β ααΆα | -24.18% |
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα | -4.47Β ααΆα | 54.71% |
ααα αΌαααΆα
αααααΆααααααα | -7.44Β ααΆα | 9.68% |
α’αααΈ
Nanobiotix is a biotechnology company that uses nanomedicine to develop new radiotherapy techniques for cancer patients. The company is headquartered in Paris, with additional corporate offices in New York and Massachusetts. Wikipedia
CEO
ααΆααααααΎαα‘αΎα
2003
αααααβαααααΆα
αα»ααααα·α
110